Latest updates for Most Favored Nation Drug Pricing

Fresh curated links around Most Favored Nation drug pricing are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • White House announces MFN agreement with drug manufacturer Regeneron
  • The Drug Companies Avoiding Trump’s Tariffs — For Now
  • White House announces deal with Regeneron to lower drug prices

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

aha.org /1 month ago

White House announces MFN agreement with drug manufacturer Regeneron

The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreem...

Read source
medcitynews.com /1 month ago

The Drug Companies Avoiding Trump’s Tariffs — For Now

Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some branded drugmakers face a reduced tariff rate, but that co...

Read source
washingtontimes.com /1 month ago

White House announces deal with Regeneron to lower drug prices

President Trump announced Thursday that he's reached a drug pricing deal with Regeneron, the last holdout among the 17 large pharmaceutical companies to agree to most-favored-natio...

Read source
washingtontimes.com /1 month ago

White House announces deal with Regeneron to lower drug prices

President Trump announced Thursday that he's reached a drug pricing deal with Regeneron, the last holdout among the 17 large pharmaceutical companies to agree to most-favored-natio...

Read source
natlawreview.com /1 month ago

Federal and State Policymakers Push Forward with PBM and Drug Pricing Reform Even in the Wake of Sweeping Actions Earlie...

Despite the flurry of reform activity throughout the first quarter of 2026, the pace of new PBM regulation and drug pricing reforms shows no sign of tapering off. Instead, both fed...

Read source
localnews8.com /1 month ago

Trump expected to impose new tariffs on certain pharmaceutical drugs

By Adam Cancryn, CNN (CNN) — President Donald Trump plans to impose new tariffs on pharmaceutical companies that have not struck deals to sell their drugs directly to consumers as...

Read source
wsls.com /1 month ago

Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative

President Donald Trump has announced a deal with Regeneron to lower the cost of its pharmaceutical products.

Read source
drugs.com /1 month ago

More Drugmakers Join TrumpRx

WEDNESDAY, April 8, 2026 — Drug companies Abbvie and Genentech will start selling medications at lower prices through the White House’s "TrumpRx" website. They are the 10th and 11t...

Read source
pharmexec.com /1 month ago

<![CDATA[More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf]]>

Read source
aha.org /1 month ago

Administration announces additional pharmaceutical tariffs

The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a 100% tariff within 12...

Read source
breitbart.com /1 month ago

Trump Strikes Deal with Regeneron Marking 17th Major Pharmaceutical Deal Since Fall

WASHINGTON—President Donald Trump announced a deal to bring state Medicaid programs access to most-favored-nation pricing on new Regeneron drugs, marking the 17th deal he has struc...

Read source
drugs.com /2 weeks ago

Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up

TUESDAY, May 12, 2026 — Since his second term started, President Donald Trump has announced, negotiated or floated a flurry of initiatives aimed at taming the excesses of the pharm...

Read source
pharmexec.com /1 month ago

<![CDATA[What Potential Fallout Will MFN Policies Have?]]>

Read source
drugs.com /1 month ago

Report Finds Drug Prices Rising Despite Trump Pricing Deals

MONDAY, April 20, 2026 — A new U.S. Senate report, released by Sen. Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to...

Read source
benzinga.com /1 month ago

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs. Importance Rank: ...

Read source
navytimes.com /3 weeks ago

Lawmakers introduce bill to lower drug costs for service members, veterans

The proposal would allow Tricare beneficiaries and VA patients to pay the lowest government-negotiated price for prescription drugs.

Read source
inc.com /1 month ago

Trump Escalates Tariff Threat Against Drugmakers, With 1 Big Condition

The White House is pressuring pharmaceutical companies to cut pricing and manufacturing deals.

Read source
pharmexec.com /1 month ago

<![CDATA[Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free]]>

Read source
drugs.com /1 month ago

U.S. Plans Tariffs up to 100% on Some Brand-Name Drugs

TUESDAY, April 7, 2026 — The United States is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs...

Read source
womansworld.com /1 week ago

Trump Adds 600 Generic Drugs to TrumpRx—Will It Save You Money?

President Donald Trump just announced that he was going to be adding more than 600 generic drugs to his federal direct-to-consumer marketplace, TrumpRx. He also said that Cost Plus...

Read source
cbsnews.com /1 month ago

2 more drug companies to officially launch on TrumpRx

Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon as Monday.

Read source
jdsupra.com /1 month ago

From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead

On April 2, 2026, President Donald Trump issued a proclamation titled “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States” (the Proclamation...

Read source
pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs]]>

Read source
mynorthwest.com /1 month ago

Trump unveils 100% tariff on some patented drugs on ‘Liberation Day’ anniversary

NEW YORK (AP) — President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Most Favored Nation Drug Pricing

feeds.benzinga.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

localnews8.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

mynorthwest.com

Recent coverage from public sources
Public source

aha.org

Recent coverage from public sources
Public source